Issue Archive
February 2026 | Volume 25 | Issue 2
Editorials
Reducing Administrative Burden in Dermatology Through Compounding Alternatives
Real-World Effectiveness of Lebrikizumab for the Prurigo Nodularis–Like Phenotype of Atopic Dermatitis: A One-Year Retrospective Study
Excimer Laser for Plaque Psoriasis: A Systematic Review and Meta-analysis
Enhancing Patient Privacy in Dermatology: Best Practices for Image Organization and Security
Original Articles
Cosmetic Procedures for Treating Lichen Planus Pigmentosus: A Review
Lichen planus pigmentosus (LPP) is a rare pigmentary disorder primarily affecting patients with skin of color. Currently, comprehensive evaluations for procedural interventions for LPP are limited in ...
Read MorePractical Algorithm for Acne Treatment Integrating Skincare and Energy-Based Devices
Background: Energy-based devices (EBDs) are increasingly used to manage acne and its sequelae. While literature supports the use of appropriate skin care for acne, few studies address how to effective...
Read MoreChatGPT and DeepSeek in Dermatologic Practice: Do Artificial Intelligence Models Adhere to Psoriasis Treatment Guidelines?
Background: The integration of artificial intelligence (AI), particularly large language models (LLMs), into healthcare has rapidly expanded. In dermatology, machine learning is increasingly employed ...
Read MoreEfficacy and Safety of Clascoterone Cream 1% for Acne Are Independent of Age and Sex
Acne vulgaris is an inflammatory skin condition affecting adolescents and adults of both sexes. Clascoterone cream 1% is indicated for the topical treatment of acne vulgaris in patients ≥12 years o...
Read MorePentoxifylline as a Steroid-Sparing Agent in Granuloma Annulare: A Rural Retrospective Study
Background: Granuloma annulare (GA) is a benign inflammatory dermatosis characterized by dermal granuloma formation. While its etiology is unclear, GA has been linked to systemic comorbidities. Locali...
Read MoreReal-World Evidence of Brodalumab Effectiveness for the Treatment of Psoriasis
Brodalumab is a recombinant, fully human monoclonal antibody antagonist of the human interleukin-17 (IL-17) receptor A. It is indicated for the treatment of moderate-to-severe plaque psoriasis in adul...
Read MoreEfficacy and Safety of Cysteamine-Isobionic Amide Complex in the Treatment of Periorbital Hyperpigmentation
Periorbital hyperpigmentation is a common yet challenging cosmetic concern due to the thin, vascular, and pigment-prone nature of periocular skin, as well as its multifactorial etiology. Discoloration...
Read MoreReview of Laser Therapy for Burn Injuries and Considerations for Burns in the Military Population
Background: Nearly 500,000 individuals seek care for burns every year in the United States. Almost one burn injury occurs every day among US service members during deployment. Severe burns can result ...
Read MoreClinical Efficacy of Second-Generation Tetracyclines as First-Line Systemic Agents for Gingival Lichen Planus
Background: Oral lichen planus (OLP) patients with erythematous or erosive gingival lesions frequently fail topical therapy. The aim of this study was to determine the efficacy of minocycline and doxy...
Read MoreRacial Disparities in United States Clinical Trial Enrollment for Mycosis Fungoides and Sézary Syndrome
Background: Racial disparities in clinical trial enrollment can limit the generalizability of therapeutic data, which is particularly damaging for conditions that disproportionately impact minority pa...
Read More
Features
What Drives the Aesthetic Journey? A Survey of the Cosmetic Concerns for African-American Women
GLP-1 Receptor Agonists in Overweight and Obese Patients With Hidradenitis Suppurativa
Reddit Discourse on Eczema: Quantitative Analysis of Misinformation, Engagement, and Alignment With 2025 American Academy of Dermatology Guidelines
Treatment of Generalized Granuloma Annulare With Biologics and Oral JAK Inhibitors: A Case Series
The Senile Cell: Understanding Cellular Senescence in Dermatology
A Systematic Evaluation of Mpox Public Health Educational Resources
Case Reports
Dual IL-17A/F Blockade for Acrodermatitis Continua of Hallopeau: A Clinical Response to Bimekizumab
Acrodermatitis continua of Hallopeau (ACH) is a rare, localized variant of pustular psoriasis that primarily affects the distal digits and nail apparatus, often presenting with recurrent pustules, nai...
Read MoreAmelioration of Dominant Dystrophic Epidermolysis Bullosa Ulceration by Combination Gentian Violet and Trichloroacetic Acid Therapy
Introduction: Dominant dystrophic epidermolysis bullosa (DDEB) is a hereditary genetic disorder with a mutation of the type VII collagen gene (COL7A1), leading to a destabilized dermal-epidermal junct...
Read More
Supplements
INDIVIDUAL ARTICLE: Evidence-Based Synthesis of Deucravacitinib: Long Term Efficacy, Safety, and Practical Use in Moderate-to-Severe Psoriasis
Background: Deucravacitinib, a first-in-class, oral, selective TYK2 inhibitor, has redefined systemic therapy options for moderate-to-severe plaque psoriasis. This review synthesizes published data fr...
Read More
